Oxidation of Benzo[a]pyrene by Recombinant Human Cytochrome P450 Enzymes

Chemical Research in Toxicology

Volumn 8, Issue 1, 1995, Pages 136-142

  Bauer, Eckhart ^a   Zeldin, Darryl ^b   Guo, Zuyu ^c   Ueng, Yune Fang ^c   Bell, L Chastine ^c   Guengerich, F Peter ^c  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; CYTOCHROME B5; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; EPOXIDE HYDROLASE; LIVER ENZYME; PHENOL DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL TISSUE; ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MICROSOME; NONHUMAN; OXIDATION; RABBIT; RAT; SACCHAROMYCES CEREVISIAE;

BENZO(A)PYRENE; BENZOFLAVONES; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; HUMAN; OXIDATION-REDUCTION; RECOMBINANT PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA; ORYCTOLAGUS CUNICULUS; SACCHAROMYCES CEREVISIAE;

EID: 0028797624     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx00043a018     Document Type: Article

References (63)

1. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, 0., Okuda, K., and Nebert, D. W. (1993) The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1–51.
2. Guengerich, F. P., and Shimada, T. (1991) Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391–407.
3. Wrighton, S. A., and Stevens, J. C. (1992) The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22, 1–21.
4. Guengerich, F. P. (1995) Human cytochrome P450 enzymes. In Cytochrome P 450 (Ortiz de Montellano, P. R., Ed.) Plenum Press, New York, in press.
5. Agency for Toxic Substances & Disease Registry (1990) Toxicological Profile for Benzo[a]pyrene, U.S. Department of Health & Human Services, Atlanta.
6. Dipple, A., Moschel, R. C., and Bigger, C. A. H. (1984) Polynuclear aromatic carcinogens. In Chemical Carcinogens (Searle, C. E., Ed.) ACS Monograph 182, pp 41–163, American Chemical Society, Washington, D.C.
7. Cook, J. W., Hewett, C. L., and Hieger, I. (1933) The isolation of a cancer-producing hydrocarbon from coal tar. Parts I, II, and III. J. Chem. Soc., 394–405.
8. Heidelberger, C. (1975) Chemical carcinogenesis. Annu. Rev. Biochem. 44, 79–121.
9. Sims, P., Grover, P., Swaisland, A., Pal, K, and Hewer, A. (1974) Metabolic activation of benzo[a]pyrene proceeds by a diol-epoxide. Nature (London) 252, 326–328.
10. Conney, A. H. (1982) Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes memorial lecture. Cancer Res. 42, 4875–4917.
11. Dipple, A., Michejda, C. J., and Weisburger, E. K. (1985) Metabolism of chemical carcinogens. Pharmacol. Ther. 27, 265–296.
12. Jerina, D. M. (1983) The 1982 Bernard B. Brodie Award lecture. Metabolism of aromatic hydrocarbons by the cytochrome P-450 system and epoxide hydrolase. Drug Metab. Dispos. 11, 1–4.
13. Wood, A. W., Levin, W., Lu, A. Y. H. Yagi, H., Hernandez, O., Jerina, D. M., and Conney, A. H. (1976) Metabolism of benzo[a]-pyrene and benzo[a]pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes. J. Biol. Chem. 251, 4882–4890.
14. Armstrong, R. N., Levin, W., Ryan, D. E., Thomas, P. E., Mah, H. D., and Jerina, D. M. (1981) Stereoselectivity of rat liver cytochrome P-450c on formation of benzo[a]pyrene 4,5-oxide. Biochem. Biophys. Res. Commun. 100, 1077–1084.
15. Wiebel, F. J., Selkirk, J. K., Gelboin, H. V., Haugen, D. A., van der Hoeven, T. A., and Coon, M. J. (1975) Position-specific oxygenation of benzo[a]pyrene by different forms of purified cytochrome P-450 from rabbit liver. 72, 3917–3920.
16. Gozukara, E. M., Guengerich, F. P., Miller, H., and Gelboin, H. V. (1982) Different patterns of benzo[a]pyrene metabolism by purified cytochrome P-450s from 3-methylcholanthrene, phenobarbital, and β-naphthoflavone treated rats: identification of the 4- and 5-phenols as new metabolites. Carcinogenesis 3, 129-134.
17. 1 metabolism in human liver microsomes by naturally occurring flavonoids. Cancer Res. 41, 67–72.
18. Kapitulnik, J., Poppers, P. J., Buening, M. K., Fortner, J. G., and Conney, A. H. (1977) Activation of monooxygenases in human liver by 7,8-benzoflavone. Clin. Pharmacol. Ther. 22, 475–485.
19. Shimada, T., Iwasaki, M., Martin, M. V., and Guengerich, F. P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of procarcinogens detected by umu gene response in Salmonella typhimurium TA1535/pSK1002. Cancer Res. 49, 3218–3228.
20. 1-450 gene. In Liver Cells and Drugs, Colloque 1NSERM Vol. 164 (Guillouzo, A., Ed.) pp 51–58, INSERM/John Libbey Eurotext Ltd., London.
21. Fujino, T., Park, S. S., West, D., and Gelboin, H. V. (1982) Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 79, 3682–3686.
22. Omiecinski, C. J., Redlich, C. A., and Costa, P. (1990) Induction and developmental expression of cytochrome P450IA1 messenger RNA in rat and human tissues: detection by the polymerase chain reaction. Cancer Res. 50, 4315–4321.
23. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C., and Tukey, R. H. (1990) Metabolism of 2-acetylaminofluorene and benzo[alpyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 50, 3367–3376.
24. Yun, C-H., Shimada, T., and Guengerich, F. P. (1992) Roles of human liver cytochrome P-4502C and 3A enzymes in the 3-hydroxylation of benzo[a]pyrene. Cancer Res. 52, 1868-1874.
25. Shimada, T., Martin, M. V., Pruess-Schwartz, D., Marnett, L. J., and Guengerich, F. P. (1989) Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo[a]pyrene, 7,8-dihydroxy-7,8-dihydrobenzo[a Ipyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons. Cancer Res. 49, 6304–6312.
26. Roberts-Thomson, S. J., McManus, M. E., Tukey, R. H., Gonzalez, F. J., and Holder, G. M. (1993) The catalytic activity of four expressed 192, human cytochrome P450s towards benzo[a)pyrene and the isomers of its proximate carcinogen. Biochem. Biophys. Res. Commun. 1373-1379.
27. Eugster, H. P., Sengstag, C., Meyer, U. A., Hinnen, A., and Würgler, F. E. (1990) Constitutive and inducible expression of human cytochrome P450IA1 in yeast Saccharomyces cerevisiae: an alternative enzyme source for in vitro studies. Biochem. Biophys. Res. Commun. 172, 737–744.
28. Ching, M. S., Lennard, M. S., Tucker, G. T., Woods, H. F., Kelly, D. E., and Kelly, S. L. (1991) The expression of human cytochrome P450IA1 in the yeast Saccharomyces cerevisiae. Biochem. Pharmacol. 42, 753—758.
29. Gautier, J.-C., Urban, P., Beaune, P., and Pompon, D. (1993) Engineered yeast cells as model to study coupling human xenobiotic metabolizing enzymes. Simulation of the the two first steps of benzo[a]pyrene activation. Eur. J. Biochem. 211, 63–72.
30. Doehmer, J., Raab, G., Holtkamp, D., Soballa, V., Schmalix, W., Greim, H., and Jacob, J. (1994) V79 hamster cells expressing human cytochromes P450. Abstracts, 10th International Symposium Microsomes Drug Oxidations, Toronto, July 17–21, pp 17–19.
31. Yang, S. K., Selkirk, J. K., Plotkin, E. V., and Gelboin, H. V. (1975) Kinetic analysis of the metabolism of benzo[a]pyrene to phenols, dihydrodiols, and quinones by high-pressure chromatography compared to analysis by aryl hydrocarbon hydyroxylase assay, and the effect of enzyme induction. Cancer Res. 35, 3642–3650.
32. Selkirk, J. K., Croy, R. G., Whitlock, J. P., Jr., and Gelboin, H. V. (1975) In vitro metabolism of benzo[a]pyrene by human liver microsomes and lymphocytes. Cancer Res. 35, 3651–3655.
33. Prough, R. A., Patrizi, V. W., Okita, R. T., Masters, B. S. S., and Jakobsson, S. W. (1979) Characteristics of benzo[a]pyrene metabolism by kidney, liver, and lung microsomal fractions from rodents and humans. Cancer Res. 39, 1199–1206.
34. Prough, R. A., Sipal, Z., and Jakobsson, S. W. (1977) Metabolism of benzo[a]pyrene by human lung microsomal fractions. Life Sci. 21, 2629–2636.
35. Gillam, E. M. J., Baba, T., Kim, B.-R., Ohmori, S., and Guengerich, F. P. (1993) Expression of modified human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of the enzyme. Arch. Biochem. Biophys. 305, 123—131.
36. Sandhu, P., Baba, T., and Guengerich, F. P. (1993) Expression of modified cytochrome P450 2C10 in Escherichia coli, purification, and reconstitution of catalytic activity. Arch. Biochem. Biophys. 306, 443–450.
37. Sandhu, P., Guo, Z., Baba, T., Martin, M. V., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A2 in Escherichia coli. Stabilization, purification, characterization, and catalytic activities of the enzyme. Arch. Biochem. Biophys. 309, 168–177.
38. Gillam, E. M. J., Guo, Z., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 2E1 in Escherichia coli, purification, and spectral and catalytic properties. Arch. Biochem. Biophys. 312, 59—66.
39. Guo, Z., Gillam, E. M. J., Ohmori, S., Tukey, R. H., and Guengerich, F. P. (1994) Expression of modified human cytochrome P450 1A1 in Escherichia coli. Effects of 5' substitution, stabilization, purification, spectral characterization, and catalytic properties. Arch. Biochem. Biophys. 312, 436—446.
40. Yasukochi, Y., and Masters, B. S. S. (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J. Biol. Chem. 251, 5337–5344.
41. Shimada, T., Misono, K. S., and Guengerich, F. P. (1986) Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction. J. Biol. Chem. 261, 909–921.
42. Funae, Y., and Imaoka, S. (1985) Simultaneous purification of multiple forms of rat liver microsomal cytochrome P-450 by highperformance liquid chromatography. Biochim. Biophys. Acta 842, 119–132.
43. Guengerich, F. P., Wang, P., Mitchell, M. B., and Mason, P. S. (1979) Rat and human liver microsomal epoxide hydratase. Purification and evidence for the existence of multiple forms. J. Biol. Chem. 254, 12248–12254.
44. Srivastava, P. K., Yun, C.-H., Beaune, P. H., Ged, C., and Guengerich, F. P. (1991) Separation of human liver tolbutamine hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. Mol. Pharmacol. 40, 69–79.
45. Lecoeur, S., Bonierbale, E., Challine, D., Gautier, J. C., Valadon, P., Dansette, P. M., Catinot, R., Ballet, F., Mansuy, D., and Beaune, P. H. (1994) Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7, 434–442.
46. Cosme, J., Maurel, P., Soucek, P., Guengerich, F. P., and Beaune, P. H. (1994) Cloning, expression and characterization of human cytochrome P-450 2C8 in heterologous systems. In Abstracts, 14th European Drug Metabolism Workshop, Paris, July 3—8, 1994.
47. 1 by bacterial recombinant human cytochrome P450 enzymes. Chem. Res. Toxicol. (in press).
48. Guengerich, F. P. (1994) Analysis and characterization of enzymes. In Principles and Methods of Toxicology (Hayes, A. W., Ed.) pp 1259–1313, Raven Press, New York.
49. Selkirk, J. K., Croy, R. G., Roller, P. P., and Gelboin, H. V. (1974) High-pressure liquid chromatographic analysis of benzo[a]pyrene metabolism and covalent binding and the mechanism of action of 7,8-benzoflavone and l,2-epoxy-3,3,3-trichloropropane. Cancer Res. 34, 3474–3480.
50. PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines, Proc. Natl. Acad. Sci. U.S.A. 86, 7696–7700.
51. Nesnow, S., and Bergman, H. (1981) Metabolism of α-naphthoflavone by rat liver microsomes. Cancer Res. 41, 2621–2626.
52. Vyas, K. P., Shibata, T., Highet, R. J., Yeh, H. J., Thomas, P. E., Ryan, D. E., Levin, W., and Jerina, D. M. (1983) Metabolism of α-naphthoflavone and β-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems. J. Biol. Chem. 258, 5649–5659.
53. Shou, M., Grogan, J., Mancewicz, J. A., Krausz, K. W., Gonzalez, F. J., Gelboin, H. V., and Korzekwa, K. R. (1994) Activation of CYP3A4: evidence for the simultaneous binding of two substrates in a cytochrome P450 active site. Biochemistry 33, 6450–6455.
54. Kitada, M., Kamataki, T., Itahashi, K, Rikihisa, T., and Kanakubo, Y. (1987) Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem. Pharmacol. 36, 453–456.
55. Hall, M., Forrester, L. M., Parker, D. K., Grover, P. L., and Wolf, C. R. (1989) Relative contribution of various forms of cytochrome P450 to the metabolism of benzo[a]pyrene by human liver microsomes. Carcinogenesis 10, 1815–1821.
56. Shou, M., Korzekwa, K. R., Crespi, C. L., Gonzalez, F. J., and Gelboin, H. V. (1994) The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol Carcinog. 10, 159–168.
57. Hayashi, S., Watanabe, J., Nakachi, K., and Kawajiri, K. (1991) Genetic linkage of lung cancer-associated Mspl polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450I A1 gene. J. Biochem. 110, 407–411.
58. Wedlund, P. J., Kimura, S., Gonzalez, F. J., and Nebert, D. W. (1994) I462V mutation in the human CYP1A1 gene: lack of correlation with either the Msp I 1.9 kb (M2) allele or CYP1A1 inducibility in a three-generation family of East Mediterranean descent. Pharmacogenetics 4, 21–26.
59. Quattrochi, L. C., Okino, S. T., Pendurthi, U. R., and Tukey, R. H. (1985) Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6. DNA 4, 395–400.
60. 1450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics 1, 20–25.
61. Kawajiri, K., Nakachi, K., Imai, K., Watanabe, J., and Hayashi, S.-I. (1993) The cytochrome P4501A1 gene and cancer susceptibility. Crit. Rev. Oncol. Hematol. 14, 77–87.
62. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P. (1994) Interindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens, and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414–423.
63. Guengerich, F. P. (1990) Mechanism-based inactivation of human liver cytochrome P-450 IIIA4 by gestodene. Chem. Res. Toxicol. 3, 363–371.